
Leuprorelin
CAS No. 53714-56-0
Leuprorelin( Leuprolide )
Catalog No. M19810 CAS No. 53714-56-0
Leuprolide is an agonist at pituitary GnRH receptors.GnRH receptor Leuprorelin is a gonadotrophin-releasing hormone (GnRH) analogue used to treat a wide range of sex hormone-related disorders including advanced prostatic cancer endometriosis and precocious puberty.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 177 | In Stock |
![]() ![]() |
10MG | 281 | In Stock |
![]() ![]() |
100MG | Get Quote | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameLeuprorelin
-
NoteResearch use only, not for human use.
-
Brief DescriptionLeuprolide is an agonist at pituitary GnRH receptors.GnRH receptor Leuprorelin is a gonadotrophin-releasing hormone (GnRH) analogue used to treat a wide range of sex hormone-related disorders including advanced prostatic cancer endometriosis and precocious puberty.
-
DescriptionLeuprolide is an agonist at pituitary GnRH receptors.GnRH receptor Leuprorelin is a gonadotrophin-releasing hormone (GnRH) analogue used to treat a wide range of sex hormone-related disorders including advanced prostatic cancer endometriosis and precocious puberty. Leuprorelin acts primarily on the anterior pituitary inducing a transient early rise in gonadotrophin release. With continued use Leuprorelin causes pituitary desensitisation and/or down-regulation leading to suppressed circulating levels of gonadotrophins and sex hormones.By interrupting the normal pulsatile stimulation of and thus desensitizing the GnRH receptors it indirectly downregulates the secretion of gonadotropins luteinizing hormone (LH) and follicle-stimulating hormone (FSH) leading to hypogonadism and thus a dramatic reduction in estradiol and testosterone levels in both sexes.
-
In Vitro——
-
In Vivo——
-
SynonymsLeuprolide
-
PathwayOthers
-
TargetOther Targets
-
RecptorGNRHR
-
Research AreaEndocrinology
-
IndicationPrecocious puberty
Chemical Information
-
CAS Number53714-56-0
-
Formula Weight1209.4
-
Molecular FormulaC59H84N16O12
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM;Water:1mg/mL
-
SMILESCCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1
-
Chemical Name(S)-N-ethyl-1-(((S)-5-oxopyrrolidine-2-carbonyl)-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl)pyrrolidine-2-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Plosker GL Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer endometriosis and other sex hormone-related disorders. Drugs.1994 Dec;48(6):930-967.
molnova catalog



related products
-
Chlormezanone
Chlormezanone, a non-benzodiazepine that is used in the management of anxiety.
-
Isoliensinine
Isoliensinine, a natural phenolic bisbenzyltetrahydroisoquinoline alkaloid, has received considerable attention for its potential biological effects such as antioxidant and anti-HIV activities.
-
Luxdegalutamide
Luxdegalutamide (ARV-766) is a novel, potent, and orally bioavailable proteolytic targeting chimera (PROTAC) protein degrader that degrades not only wild-type AR but also clinically relevant AR LBD mutants, including the most prevalent AR L702H, H875Y, and T878A mutations.